Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry|January 16, 2008
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moietyRobert Rönn, Anna Lampa, Shane D Peterson, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2017
Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1Daniel P Mould, Ulf Bremberg, Allan M Jordan, et al.
Biochemistry|August 8, 2019
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3Edoardo Fabini, Vladimir O Talibov, Filip Mihalic, et al.
Analytical Chemistry|October 26, 2019
Structural Changes of Mercaptohexanol Self-Assembled Monolayers on Gold and Their Influence on Impedimetric Aptamer SensorsXingxing Xu, Asta Makaraviciute, Shalen Kumar, et al.
RSC Medicinal Chemistry|June 24, 2024
Identification of fragments targeting SMYD3 using highly sensitive kinetic and multiplexed biosensor-based screeningEdward A FitzGerald, Daniela Cederfelt, Bjarte Aarmo Lund, et al.
Bioorganic & Medicinal Chemistry|August 3, 2010
Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinonesPernilla Ortqvist, Johan Gising, Angelica E Ehrenberg, et al.
Antiviral Therapy|September 14, 2010
Structure-activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168VPernilla Ortqvist, Aparna Vema, Angelica E Ehrenberg, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocyclesAnna Lampa, Hiba Alogheli, Angelica E Ehrenberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2017
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1Daniel P Mould, Ulf Bremberg, Allan M Jordan, et al.
Pageof 13